改良额肌瓣悬吊术矫治重度上睑下垂的临床疗效观察

目的 探讨改良额肌瓣悬吊术矫治重度上睑下垂的临床疗效.方法 对重度上睑下垂患者40例71只眼,采用改良的两侧不断蒂的扇形额肌瓣悬吊术进行矫治,分析术后上睑下垂矫正效果,上睑缘弧度、重睑形成及倒睫、结膜脱垂等并发症发生情况.结果 随访观察6～18个月,平均11.6个月.术后过矫6只眼(8.5%),欠矫2只眼(2.8%).其余患者睑裂对称,上睑弧度自然,重睑形成好.3个月后无回退、复发.术后并发症包括结膜脱垂2只眼(2.8%).应用皮质类固醇激素眼药水点眼,加压包扎,结膜脱垂消失;内翻倒睫1只眼(1.4%).上睑内侧1/3灰线处缝牵引缝线牵引后矫正内翻倒睫.结论 改良额肌瓣悬吊术矫治重度上睑下垂疗效满意,效果持久稳定、安全可靠.

Clinical observation of severe blepharoptosis correction with modified frontalis muscle suspension

Objective To explore the clinical effect of modified frontalis muscle suspension for severe blepharoptosis correction. Methods A total of 40 cases (71 eyes) with severe blepharoptosis underwent modified frontalis muscle suspension. Results The follow-up period ranged from 6 to 18 months (mean 11.6 months). One case (2 eyes ) required reoperation for undercorrection, 3 cases (6 eyes) for overcorrection. Complications such as ectropion and corneal exposure were avoided, but 1 eye was trichomatous and 2 cases of 4 eyes were conjunetival prolapsed. There was no recurrence after 3 months. Conclusions The study shows that this surgical technique is a perfect method to treat severe blepharoptosis and predictable with few complications.